HIV pre-exposure prophylaxis (PrEP) for women: Claiming risk and recognizing responsibility to end the AIDS epidemic in New York
Introduction: When the drug Truvada was approved for use as pre-exposure prophylaxis (PrEP) to prevent HIV in 2012, it was lauded as the first major advance in HIV prevention in decades and a major step toward reaching the goal of ending the epidemic. However, concerns around equitable access to PrE...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Edizioni FS
2020-12-01
|
| Series: | Journal of Health and Social Sciences |
| Subjects: | |
| Online Access: | https://journalhss.com/wp-content/uploads/jhss_501-512.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|